USFDA APPROVED RAPID ACTING INSULIN LISPRO AABC FROM ELI LILLY COMPANY

Dear my friends and fellow Colleagues, Here is an update on Rapid Acting Insulin LISPRO aabc, approved by USFDA. USFDA Approves rapid acting Insulin Lispro-aabc ( Lyumjev-Eli Lilly) for treatment of Type1 & Type2 Diabetes. It will be available in U-100 & U-200 strengths. Early half maximal drug concentration is reached at 13 minutes with Lyumjev compared to 19 minutes with Fiasp, June, 2020 Regards and thanks, Dr Sepuri Krishna Mohan

9 Likes

LikeAnswersShare
Very useful n informative post
Thank you doctor
0
Nice and useful update.
Thank you doctor
0

View 3 other replies

Nice information ! Sir
Thank you doctor
1
NICE AND USEFUL UPDATE
Valuable opinion
0
Nice information sir
Thank you doctor
0
Useful update, sir
Thank you doctor
0
As i remember it is newer insulin lispro which is used in resistant cases of human insulin.it is given in 10 iu sc to start with in evening before dinner.personel view. Thanks for sharing.
Thank you doctor
0
Thank you doctor
0